Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 7: Special Focus: VR6 Conference
Submit an article Journal homepage
1,479
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines

A single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China

Xue-en Liu Department of Microbiology and Center of Infectious Disease; School of Basic Medicine; Peking University Health Science Center; Beijing, P.R. China
,
Fuerhati Wushouer Xinjiang Uighur Autonomous Region Center for Disease Control and Prevention; Urumqi, Xinjiang, P.R. China
,
Aili Gou Xinjiang Uighur Autonomous Region Center for Disease Control and Prevention; Urumqi, Xinjiang, P.R. China
,
Mahemuti Kuerban Xinjiang Uighur Autonomous Region Center for Disease Control and Prevention; Urumqi, Xinjiang, P.R. China
,
Xinlan Li Xinjiang Uighur Autonomous Region Center for Disease Control and Prevention; Urumqi, Xinjiang, P.R. China
,
Yubo Sun Changji City Center for Disease Control and Prevention; Changji, Xinjiang, P.R. China
,
Jiamin Zhang Changji City Center for Disease Control and Prevention; Changji, Xinjiang, P.R. China
,
Yan Liu Sinovac Biotech Co. Ltd.; Beijing, P.R. China
,
Jie Li Department of Microbiology and Center of Infectious Disease; School of Basic Medicine; Peking University Health Science Center; Beijing, P.R. China
&
Hui Zhuang Department of Microbiology and Center of Infectious Disease; School of Basic Medicine; Peking University Health Science Center; Beijing, P.R. ChinaCorrespondence[email protected]
 show all
Pages 1460-1465 | Received 21 Jan 2013, Accepted 19 Mar 2013, Published online: 09 Apr 2013

References

  • Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev 2006; 28:101 - 11; http://dx.doi.org/10.1093/epirev/mxj012; PMID: 16775039
  • Hepatitis A vaccination. World Health Organization. Accessed at http://www.who.int/vaccines/en/hepatitisa.shtml
  • WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec 2012; 87:261 - 76; PMID: 22905367
  • Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294:202 - 10; http://dx.doi.org/10.1001/jama.294.2.202; PMID: 16014594
  • Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004; 22:4342 - 50; http://dx.doi.org/10.1016/j.vaccine.2004.04.014; PMID: 15474727
  • Fangcheng Z, Xuanyi W, Mingding C, Liming J, Jie W, Qi J, et al. Era of vaccination heralds a decline in incidence of hepatitis A in high-risk groups in China. Hepat Mon 2012; 12:100 - 5; http://dx.doi.org/10.5812/hepatmon.4907; PMID: 22509186
  • Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L, Hepatitis A. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4:68 - 73; http://dx.doi.org/10.4254/wjh.v4.i3.68; PMID: 22489258
  • Koslap-Petraco MB, Shub M, Judelsohn R. Hepatitis A: disease burden and current childhood vaccination strategies in the United States. J Pediatr Health Care 2008; 22:3 - 11; http://dx.doi.org/10.1016/j.pedhc.2006.12.011; PMID: 18174084
  • Hollinger FB, Bell B, Levy-Bruhl D, Shouval D, Wiersma S, Van Damme P. Hepatitis A and B vaccination and public health. J Viral Hepat 2007; 14:Suppl 1 1 - 5; http://dx.doi.org/10.1111/j.1365-2893.2007.00924.x; PMID: 17958635
  • Zheng H, Cui FQ. [The immunogenicity and impact factors of hepatitis A attenuated live vaccine and inactivated vaccine]. Zhongguo Yi Miao He Mian Yi 2009; 15:371 - 4; PMID: 20077742
  • Wang XY, Xu ZY, Ma JC, von Seidlein L, Zhang Y, Hao ZY, et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine 2007; 25:446 - 9; http://dx.doi.org/10.1016/j.vaccine.2006.08.004; PMID: 16949710
  • Wang XY, Xu Z, Yao X, Tian M, Zhou L, He L, et al. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines. Vaccine 2004; 22:1941 - 5; http://dx.doi.org/10.1016/j.vaccine.2003.11.007; PMID: 15121306
  • Van Herck K, Crasta PD, Messier M, Hardt K, Van Damme P. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine. Hum Vaccin Immunother 2012; 8:323 - 7; PMID: 22327499
  • Zhuang FC, Jiang Q, Gong YP, Me SH, Xin YJ, Qian W, et al. Epidemiological effects of live attenuated hepatitis A vaccine (H2 strain); results of 10-year observation. Chin J Epidemiol 2001; 22:188 - 90
  • Iwarson S, Lindh M, Widerström L. Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine. J Travel Med 2004; 11:120 - 1; http://dx.doi.org/10.2310/7060.2004.17079; PMID: 15109480
  • Vacchino MN. Incidence of Hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15:Suppl 2 47 - 50; http://dx.doi.org/10.1111/j.1365-2893.2008.01029.x; PMID: 18837834
  • André F, Van Damme P, Safary A, Banatvala J. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use. Expert Rev Vaccines 2002; 1:9 - 23; http://dx.doi.org/10.1586/14760584.1.1.9; PMID: 12908508
  • Van Herck K, Van Damme P. Prevention of hepatitis A by Havrix: a review. Expert Rev Vaccines 2005; 4:459 - 71; http://dx.doi.org/10.1586/14760584.4.4.459; PMID: 16117704
  • Wu JY, Liu Y, Chen JT, Xia M, Zhang XM. Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®. Hum Vaccin Immunother 2012; 8:1 - 9; http://dx.doi.org/10.4161/hv.21909; PMID: 22251991

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.